|
1
|
Little JL and Kridel SJ: Fatty acid
synthase activity in tumor cells. Subcell Biochem. 49:169–194.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kusakabe T, Maeda M, Hoshi N, Sugino T,
Watanabe K, Fukuda T and Suzuki T: Fatty acid synthase is expressed
mainly in adult hormone-sensitive cells or cells with high lipid
metabolism and in proliferating fetal cells. J Histochem Cytochem.
48:613–622. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gansler TS, Hardman W III, Hunt DA,
Schaffel S and Hennigar RA: Increased expression of fatty acid
synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Hum Pathol. 28:686–692. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahiro T, Shinichi K and Toshimitsu S:
Expression of fatty acid synthase as a prognostic indicator in soft
tissue sarcomas. Clin Cancer Res. 9:2204–2212. 2003.PubMed/NCBI
|
|
5
|
Rossi S, Graner E, Febbo P, Weinstein L,
Bhattacharya N, Onody T, Bubley G, Balk S and Loda M: Fatty acid
synthase expression defines distinct molecular signatures in
prostate cancer. Mol Cancer Res. 1:707–715. 2003.PubMed/NCBI
|
|
6
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Migita T, Ruiz S, Fornari A, Fiorentino M,
Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E,
et al: Fatty acid synthase: A metabolic enzyme and candidate
oncogene in prostate cancer. J Natl Cancer Inst. 101:519–532. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piyathilake CJ, Frost AR, Manne U, Bell
WC, Weiss H, Heimburger DC and Grizzle WE: The expression of fatty
acid synthase (FASE) is an early event in the development and
progression of squamous cell carcinoma of the lung. Hum Pathol.
31:1068–1073. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swinnen JV, Roskams T, Joniau S, Van
Poppel H, Oyen R, Baert L, Heyns W and Verhoeven G: Overexpression
of fatty acid synthase is an early and common event in the
development of prostate cancer. Int J Cancer. 98:19–22. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Innocenzi D, Alò PL, Balzani A, Sebastiani
V, Silipo V, La Torre G, Ricciardi G, Bosman C and Calvieri S:
Fatty acid synthase expression in melanoma. J Cutan Pathol.
30:23–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Omura S: The antibiotic cerulenin, a novel
tool for biochemistry as an inhibitor of fatty acid synthesis.
Bacteriol Rev. 40:681–697. 1976.PubMed/NCBI
|
|
12
|
Pizer ES, Jackisch C, Wood FD, Pasternack
GR, Davidson NE and Kuhajda FP: Inhibition of fatty acid synthesis
induces programmed cell death in human breast cancer cells. Cancer
Res. 56:2745–2747. 1996.PubMed/NCBI
|
|
13
|
Zhao W, Kridel S, Thorburn A, Kooshki M,
Little J, Hebbar S and Robbins M: Fatty acid synthase: A novel
target for antiglioma therapy. Br J Cancer. 95:869–878. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuhajda FP, Pizer ES, Li JN, Mani NS,
Frehywot GL and Townsend CA: Synthesis and antitumor activity of an
inhibitor of fatty acid synthase. Proc Natl Acad Sci USA.
97:3450–3454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alli PM, Pinn ML, Jaffee EM, McFadden JM
and Kuhajda FP: Fatty acid synthase inhibitors are chemopreventive
for mammary cancer in neu-N transgenic mice. Oncogene.
24:39–46. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang HQ, Altomare DA, Skele KL, Poulikakos
PI, Kuhajda FP, Di Cristofano A and Testa JR: Positive feedback
regulation between AKT activation and fatty acid synthase
expression in ovarian carcinoma cells. Oncogene. 24:3574–3582.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thupari JN, Pinn ML and Kuhajda FP: Fatty
acid synthase inhibition in human breast cancer cells leads to
malonyl-CoA-induced inhibition of fatty acid oxidation and
cytotoxicity. Biochem Biophys Res Commun. 285:217–223. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barger JF and Plas DR: Balancing
biosynthesis and bioenergetics: Metabolic programs in oncogenesis.
Endocr Relat Cancer. 17:R287–R304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel AV, Johansson G, Colbert MC,
Dasgupta B and Ratner N: Fatty acid synthase is a metabolic
oncogene targetable in malignant peripheral nerve sheath tumors.
Neuro Oncol. 17:1599–1608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bandyopadhyay S, Pai SK, Watabe M, Gross
SC, Hirota S, Hosobe S, Tsukada T, Miura K, Saito K, Markwell SJ,
et al: FAS expression inversely correlates with PTEN level in
prostate cancer and a PI 3-kinase inhibitor synergizes with FAS
siRNA to induce apoptosis. Oncogene. 24:5389–5395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang F and Du G: Dysregulated lipid
metabolism in cancer. World J Biol Chem. 3:167–174. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Finck BN and Kelly DP: PGC-1 coactivators:
Inducible regulators of energy metabolism in health and disease. J
Clin Invest. 116:615–622. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang WG, Douglas-Jones A and Mansel RE:
Expression of peroxisome-proliferator activated receptor-γ
(PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast
cancer correlates with clinical outcomes. Int J Cancer.
106:752–757. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watkins G, Douglas-Jones A, Mansel RE and
Jiang WG: The localisation and reduction of nuclear staining of
PPARγ and PGC-1 in human breast cancer. Oncol Rep. 12:483–488.
2004.PubMed/NCBI
|
|
25
|
Feilchenfeldt J, Bründler MA, Soravia C,
Tötsch M and Meier CA: Peroxisome proliferator-activated receptors
(PPARs) and associated transcription factors in colon cancer:
Reduced expression of PPARgamma-coactivator 1 (PGC-1). Cancer Lett.
203:25–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Ba Y, Liu C, Sun G, Ding L, Gao
S, Hao J, Yu Z, Zhang J, Zen K, et al: PGC-1α induces apoptosis in
human epithelial ovarian cancer cells through a PPARγ-dependent
pathway. Cell Res. 17:363–373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shiota M, Yokomizo A, Tada Y, Inokuchi J,
Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N and Naito S:
Peroxisome proliferator-activated receptor γ coactivator-1α
interacts with the androgen receptor (AR) and promotes prostate
cancer cell growth by activating the AR. Mol Endocrinol.
24:114–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shin SW, Yun SH, Park ES, Jeong JS, Kwak
JY and Park JI: Overexpression of PGC-1α enhances cell
proliferation and tumorigenesis of HEK293 cells through the
upregulation of Sp1 and Acyl-CoA binding protein. Int J Oncol.
46:1328–1342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vock C, Biedasek K, Boomgaarden I, Heins
A, Nitz I and Döring F: ACBP knockdown leads to down-regulation of
genes encoding rate-limiting enzymes in cholesterol and fatty acid
metabolism. Cell Physiol Biochem. 25:675–686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee MY, Moon JS, Park SW, Koh YK, Ahn YH
and Kim KS: KLF5 enhances SREBP-1 action in androgen-dependent
induction of fatty acid synthase in prostate cancer cells. Biochem
J. 417:313–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quah BJ, Warren HS and Parish CR:
Monitoring lymphocyte proliferation in vitro and in vivo with the
intracellular fluorescent dye carboxyfluorescein diacetate
succinimidyl ester. Nat Protoc. 2:2049–2056. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shin SW, Seo CY, Han H, Han JY, Jeong JS,
Kwak JY and Park JI: 15d-PGJ2 induces apoptosis by reactive oxygen
species-mediated inactivation of Akt in leukemia and colorectal
cancer cells and shows in vivo antitumor activity. Clin Cancer Res.
15:5414–5425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ishimura N, Amano Y, Sanchez-Siles AA,
Fukuhara H, Takahashi Y, Uno G, Tamagawa Y, Mishima Y, Yuki T,
Ishihara S, et al: Fatty acid synthase expression in Barrett's
esophagus: Implications for carcinogenesis. J Clin Gastroenterol.
45:665–672. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wellberg EA, Rudolph MC, Lewis AS,
Padilla-Just N, Jedlicka P and Anderson SM: Modulation of tumor
fatty acids, through overexpression or loss of thyroid hormone
responsive protein spot 14 is associated with altered growth and
metastasis. Breast Cancer Res. 16:4812014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yellen P and Foster DA: Inhibition of
fatty acid synthase induces pro-survival Akt and ERK signaling in
K-Ras-driven cancer cells. Cancer Lett. 353:258–263. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong S, Chirala SS and Wakil SJ: Sterol
regulation of human fatty acid synthase promoter I requires nuclear
factor-Y- and Sp-1-binding sites. Proc Natl Acad Sci USA.
97:3948–3953. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Summermatter S, Baum O, Santos G, Hoppeler
H and Handschin C: Peroxisome proliferator-activated receptor
{gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal
muscle lipid refueling in vivo by activating de novo lipogenesis
and the pentose phosphate pathway. J Biol Chem. 285:32793–32800.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zaytseva YY, Elliott VA, Rychahou P,
Mustain WC, Kim JT, Valentino J, Gao T, O'Connor KL, Neltner JM,
Lee EY, et al: Cancer cell-associated fatty acid synthase activates
endothelial cells and promotes angiogenesis in colorectal cancer.
Carcinogenesis. 35:1341–1351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zaytseva YY, Rychahou PG, Gulhati P,
Elliott VA, Mustain WC, O'Connor K, Morris AJ, Sunkara M, Weiss HL,
Lee EY, et al: Inhibition of fatty acid synthase attenuates
CD44-associated signaling and reduces metastasis in colorectal
cancer. Cancer Res. 72:1504–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sounni NE, Cimino J, Blacher S, Primac I,
Truong A, Mazzucchelli G, Paye A, Calligaris D, Debois D, De Tullio
P, et al: Blocking lipid synthesis overcomes tumor regrowth and
metastasis after antiangiogenic therapy withdrawal. Cell Metab.
20:280–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Seguin F, Carvalho MA, Bastos DC, Agostini
M, Zecchin KG, Alvarez-Flores MP, Chudzinski-Tavassi AM, Coletta RD
and Graner E: The fatty acid synthase inhibitor orlistat reduces
experimental metastases and angiogenesis in B16-F10 melanomas. Br J
Cancer. 107:977–987. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chajès V, Cambot M, Moreau K, Lenoir GM
and Joulin V: Acetyl-CoA carboxylase alpha is essential to breast
cancer cell survival. Cancer Res. 66:5287–5294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel
W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L, et al:
PGC1α promotes tumor growth by inducing gene expression programs
supporting lipogenesis. Cancer Res. 71:6888–6898. 2011. View Article : Google Scholar : PubMed/NCBI
|
